J Korean Ophthalmol Soc.  1995 Feb;36(2):307-315.

The Effects of Topical Cyclosporin A on Glaucoma Drainage Implant Surgery in Rabbits

Affiliations
  • 1Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea.

Abstract

To assess the effects of topical cyclosporin A(Csa) on the function of fibrous capsule and fibroblast proliferation after glaucoma drainage implant surgery in rabbits, we compared intraocular pressure(IOP), outflow resistance through the capsule and fibroblast density in capsule and fibroblast density in capsule among three groups: group A(12 eyes) that received implant surgery only, group B(11eyes) trated with topical 2% CsA twice a day for 2 weeks after implant surgery, and group C(14 eyes) with intraoperative subcon-junctival soaking of 2% CsA for S minutes and postoperative topical 2% CsA twice a day for 2 weeks. There was significant postoperative IOP decreases at 2, 4 and 8 weeks in group B(7.3 +/- 2.0. 7.1 +/- 1.7, and 6.6 +/- 1.8 mmHg, respectively) and group C(7.8 +/- 2.6, 7.1 +/- 1.7, and 6.8 +/- 1.6 mmHg, respectively) compared with group A(5.1 +/- 1.7, 5.0 +/- 1.0, and 4.8 +/- 1.5 mmHg, respectively)(p<0.01 for each). Flow resistances at postoperative 8 weeks were significantly lower in group Band group C than in group A(n=3. p<0.01). There was no significant difference in postoperative IOP decrease and outflow resistance between group B and Group C(p>0.05 for each). Fibroblast density was not significantly lower in group B and Group C than in group A(n=3, p=0.08). These results suggest adjunctive topical CsA may enhance the effectiveness of glaucoma drainage implant surgery.

Keyword

Cyclosporin A; Fibroblast; Glaucoma drainage implant surgery; Intraocular pressure; Outflow resistance

MeSH Terms

Cyclosporine*
Fibroblasts
Glaucoma Drainage Implants*
Glaucoma*
Intraocular Pressure
Rabbits*
Cyclosporine
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr